Immunocytochemical differentiation of canine mesenchymal tumors in cytologie imprint preparations

Veterinary Clinical Pathology

Volumn 37, Issue 1, 2008, Pages 104-111

  Hoinghaus R ^a   Hewicker Trautwein, M ^a   Mischke, Reinhard ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antibodies; Dog; Immunocytochemistry; Mesenchymal tumor

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSIFICATION; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; NEOPLASM; PATHOLOGY;

ANIMALS; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS;

CANIS FAMILIARIS;

EID: 44449115153     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2008.00017.x     Document Type: Article

References (40)

1. Meinkoth JH, Cowell RL. Recognition of basic cell types and criteria of malignancy. Vet Clin North Am Small Anim Pract. 2002;32:1209-1235.
2. Dabbs D. Diagnostic Immunohistochemistry. 2nd ed. Philadelphia, PA: Churchill Livingston, Elsevier; 2006.
3. Moore AS, Madewell BR, Lund JK. Immunohistochemical evaluation of intermediate filament expression in canine and feline neoplasms. Am J Vet Res. 1989;50:88-92.
4. Moll R. Cytokeratine als Differenzierungsmarker: Expressionsprofile von Epithelien und Epithelialen Tumoren [Cytokeratins as Markers of Differentiation: Expression Profiles of Epithelia and Epithelial Tumors]. Stuttgart, Germany: Gustav Fischer Verlag; 1993.
5. Orosz Z. Melan-A/MART-1 expression in various melanocytic lesions and non-myelocytic soft tissue tumours. Histopathology. 1999;34:517-525.
6. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology. 2000;36:387-402.
7. Orchard GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J. 2000;32:475-481.
8. Von Beust BR, Suter MM, Summers BA. Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study. Vet Pathol. 1988;25:251-255.
9. Ohsawa M, Naka N, Tomita Y, et al. Use of immunohistochemical procedures in diagnosing angiosarcoma: evaluation of 98 cases. Cancer. 1995;75:2867-2874.
10. Moore PF. Utilization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in canine histiocytic disorders. Vet Pathol. 1986;23:757-762.
11. Höinghaus R, Hewicker-Trautwein M, Mischke R. Immunocytochemical differentiation of neoplastic and hyperplastic canine epithelial lesions in cytologic imprint preparations. Vet J. 2007;173:79-90.
12. Tseng SCG, Jarvinen MJ, Nelson WG, Huang JW, Woodcock-Mitchell J, Sun TT. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell. 1982;30:361-372.
13. Denk H, Krepler R, Artlieb U, et al. Proteins of intermediate filaments: an immunohistochemical and biochemical approach to the classification of soft tissue tumors. Am J Pathol. 1983;110:193-208.
14. Miettinen M, Letho VP, Badley RA, Virtanan I. Expression of intermediate filaments in soft-tissue sarcomas. Int J Cancer. 1982;15:541-546.
15. Takahashi K, Isobe T, Ohtsuki Y, Akagi T, Sonobe H, Okuyama T. Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol. 1984;45:385-396.
16. Moller AC, Hellmen E. S 100 protein is not specific for myoepithelial cells in the canine mammary gland. J Comp Pathol. 1994;110:49-55.
17. Busam KJ, Iversen K, Coplan KA, et al. Immuno-reactivity for A 103, an antibody to melan-A (MART-1), in adrenocortical and other steroid tumors. Am J Surg Pathol. 1998;22:57-63.
18. Bloom AL, Giddings JC, Wilks CJ. Factor VIII on the vascular intima: possible importance in heamostasis and thrombosis. Nat New Biol. 1973;241:217-219.
19. Mason DY, Taylor CR. The distribution of muramidase (lysozyme) in human tissue. J Clin Pathol. 1975;28:124-132.
20. Altmannsberger M, Osborn M, Droese M, Weber K, Schauer A. Diagnostic value of intermediate filament antibodies in clinical cytology. Klin Wochenschr. 1984;62:114-123.
21. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. Am J Clin Pathol. 1985;84:413-424.
22. Chosia M, Gaulier A, Marsan C. Initial immunolabelling in the diagnosis of solid tumors undergoing cytologie studies (cytopuncture and imprints) [in French]. Arch Anat Cytol Pathol. 1989;37:99-108.
23. Andreasen CB, Mahaffey EA, Duncan JR. Intermediate filament staining in the cytologie and histologic diagnosis of canine skin and soft tissue tumors. Vet Pathol. 1988;25:343-349.
24. Desnoyers M, Haines DM, Searcy GP. Immunohistochemical detection of intermediate filament protein in formalin fixed normal and neoplastic canine tissues. Can J Vet Res. 1990;54:360-365.
25. Kim DY, Hodgin EC, Cho DY, Varnado JE. Juvenile rhabdomyosarcomas in two dogs. Vet Pathol. 1996;33:447-450.
26. Kuwamura M, Yoshida H, Yamate J, Kotani T, Ohashi F, Sakuma S. Urinary bladder rhabdomyosarcoma (sarcoma botryoidesj in a young Newfoundland dog. J Vet Med Sci. 1998;60:619-621.
27. Andreasen CB, Mahaffay EA. Immunohistochemical demonstration of desmin in canine smooth muscle tumors. Vet Pathol. 1987;24:211-215.
28. La Rock RG, Ginn PE. Immunohistochemical staining characteristics of canine gastrointestinal stromal tumors. Vet Pathol. 1997:34:303-311.
29. Frost D, Lasota J, Miettinen M. Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases. Vet Pathol. 2003;40:42-54.
30. Evans DJ, Lampert IA, Jacobs M. Intermediate filaments in smooth muscle tumors. J Clin Pathol. 1983;36:57-61.
31. Ramos-Vara JA, Beissenherz ME, Miller MA, et al. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol. 2000;37:597-608.
32. Coccia D, Lauriola L, Stolfi VM, Tallini G, Michetti F. S-100 labels neoplastic cells in liposarcoma and cartilaginous tumours. Virchows Arch A Pathol Anat Histopathol. 1983;402:139-145.
33. Kahn HJ, Marks A, Thorn H, Baumal R. Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol. 1983:79:341-347.
34. Drier JK, Swanson PE, Cherwitz DL, Wick MR. S 100 protein immunoreactivity in poorly differentiated carcinomas. Arch Pathol Lab Med. 1987;111:447-452.
35. Okajima K, Honda I, Kitagawa T. Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage. Cancer. 1988;61:792-799.
36. Stroup RM, Pinkus GS. S-100 immunoreactivity in primary and metastatic carcinoma of the breast. Hum Pathol. 1988;19:949-953.
37. Höinghaus R, Mischke R, Hewicker-Trautwein M. Use of immunocytochemical techniques in canine melanoma. J Vet Med A. 2002;49:198-202.
38. Jungbluth AA, Busam KJ, Gerald WL, et al. A103: an anti-melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol. 1998;22:595-602.
39. Sulaimon S, Kitchell B, Ehrhart E. Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma. J Comp Pathol. 2002;127:162-168.
40. Hurliman J. Desmin and neural marker expression in mesothelial cells and mesothelioma. Hum Pathol. 1994;25:753-757.